ADMA vs TYL · P/E 22, rev $238.9M vs P/E 89, rev $1.26B
ADMA Biologics Inc (ADMA) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the ADMA and TYL stock pages for the full models.
Not investment advice.